about
International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligandsTargeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activityRole of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapyGPR35 activation reduces Ca2+ transients and contributes to the kynurenic acid-dependent reduction of synaptic activity at CA3-CA1 synapsesLabel-free phenotypic profiling identified D-luciferin as a GPR35 agonistInternational Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature.The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsIdentification of novel species-selective agonists of the G-protein-coupled receptor GPR35 that promote recruitment of β-arrestin-2 and activate Gα13.Gintonin, newly identified compounds from ginseng, is novel lysophosphatidic acids-protein complexes and activates G protein-coupled lysophosphatidic acid receptors with high affinity.Alteration of fatty-acid-metabolizing enzymes affects mitochondrial form and function in hereditary spastic paraplegia.Aiming drug discovery at lysophosphatidic acid targets.High-throughput identification and characterization of novel, species-selective GPR35 agonists.Screening β-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors.Subgroup-elimination transcriptomics identifies signaling proteins that define subclasses of TRPV1-positive neurons and a novel paracrine circuit.The therapeutic potential of orphan GPCRs, GPR35 and GPR55.Lysophosphatidic Acid and Sphingosine-1-Phosphate: A Concise Review of Biological Function and Applications for Tissue Engineering.Role of GPR55 during Axon Growth and Target Innervation.A potential role for GPR55 in gastrointestinal functionsStratified approaches to the treatment of asthma.G-Protein-Coupled Receptor 35 Mediates Human Saphenous Vein Vascular Smooth Muscle Cell Migration and Endothelial Cell Proliferation.De novo microduplications at 1q41, 2q37.3, and 8q24.3 in patients with VATER/VACTERL association.The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat GPR35Intercellular Lipid Mediators and GPCR Drug DiscoveryCrucial positively charged residues for ligand activation of the GPR35 receptor.Low affinity GPCRs for metabolic intermediates: challenges for pharmacologists.Genetics in PSC: what do the "risk genes" teach us?G protein-coupled receptor 35: an emerging target in inflammatory and cardiovascular disease.Stress, depression, resilience and ageing: A role for the LPA-LPA1 pathway.Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer.Discovery of 2-(4-methylfuran-2(5H)-ylidene)malononitrile and thieno[3,2-b]thiophene-2-carboxylic acid derivatives as G protein-coupled receptor 35 (GPR35) agonists.Neuro-psychopharmacological perspective of Orphan receptors of Rhodopsin (class A) family of G protein-coupled receptors.Discovery of Natural Phenols as G Protein-Coupled Receptor-35 (GPR35) Agonists.GPR35 as a Novel Therapeutic Target.Synthesis and Agonistic Activity at the GPR35 of 5,6-Dihydroxyindole-2-carboxylic Acid Analogues.Antagonists of GPR35 display high species ortholog selectivity and varying modes of action.Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on MigraineMultiple tyrosine metabolites are GPR35 agonists.Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms.The Three Catecholics Benserazide, Catechol and Pyrogallol are GPR35 Agonists.GPR35 mediates lodoxamide-induced migration inhibitory response but not CXCL17-induced migration stimulatory response in THP-1 cells; is GPR35 a receptor for CXCL17?
P2860
Q24605072-1DE470B5-A83F-47D4-B91A-E2BE7C65AD78Q24605869-B12EBB77-B9AF-461D-8054-3C477449D27BQ27015257-8C46BCFD-492A-405C-95C6-BE70C6849031Q28535496-AB582756-66D2-4654-848E-DC0B81C8337AQ28730612-BE5F4308-7122-4A69-905C-3AA26FF6F3FDQ30429523-4CF72FF4-99F2-476A-88E0-F82BF6D2DF50Q30486707-183B91AC-5F5E-4353-BB70-DE472753D258Q30990011-103902D0-1576-4304-9C9C-8DCF95E4A4E5Q34250421-635526AC-9489-4FFB-B487-4845F337228DQ34313405-638498E0-9472-46FC-BB2F-94603E3957A4Q34339759-0F7F69E9-5B4C-46A0-8CEA-22614063EBE5Q34520909-D86CC98C-E962-41CE-9093-49634786A793Q34581803-855982ED-27F1-4FEA-9951-40C728263B6FQ34796577-CB8932D7-505E-4CFD-BC17-5A1635F891A2Q35425244-06828F4E-357F-4C71-804F-3A294F2997ACQ36330107-298E5609-4E74-45B0-BA20-4369AD0DA11FQ36426297-F0B0592D-8A81-4332-B1CE-FEE086051F63Q36864469-B0DFE2AF-AC7E-4CB7-8354-D0CF2102D714Q37064755-FC8FA86B-816B-44CC-985C-97BE20072D3EQ37122933-C9855595-2B2B-498E-9B54-C5D86F517A40Q37316976-071A31BB-5202-4EC4-BB86-CBB978BE14B4Q37405405-620A6E1C-3E3B-4E82-A002-39D9C5554885Q37429742-BCB6A6AB-2920-4FEC-8CA8-3D0C99B16E1BQ37563536-8C7607A7-097E-4324-88A6-88FA256E3465Q38014830-E4F11E50-B109-4CB0-8209-84ADA2585496Q38204911-E35DE893-57BE-4455-BE63-A9BE1768E32DQ38389922-0785B85F-B696-41D0-9C9D-9B31DA44FD71Q38658765-235369FE-0954-4E88-AD2C-D7BA777411B8Q38660494-354135CF-18B1-41B8-96D0-708429938623Q38775057-73A1FF9E-4F53-4839-94A8-310AF929A32CQ39176941-DBF91E21-2DB1-4FA6-8648-3EF720B68888Q39731165-413B6453-1B32-4AA3-8F9D-952B48588876Q39799967-55602921-8559-49C9-B7D5-F86F8B005A53Q39867411-F64528E2-67AE-410B-A500-614975FC5EF3Q41401817-089C364F-FF56-41C4-A1AF-EF268158E950Q41572995-018FFE44-4006-4D3A-9774-9D606145622AQ42538150-C3A5FAC5-9644-4595-BA41-A2D60EF4B1D9Q42700473-C1FF4CDE-D324-499C-B927-21811DB0847CQ42922733-C4A85BC9-D8C4-4B46-8FBD-026F81DE05B1Q47606629-268BA9E1-2568-40B2-974F-149159418F96
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
GPR35 is a novel lysophosphatidic acid receptor.
@en
GPR35 is a novel lysophosphatidic acid receptor.
@nl
type
label
GPR35 is a novel lysophosphatidic acid receptor.
@en
GPR35 is a novel lysophosphatidic acid receptor.
@nl
prefLabel
GPR35 is a novel lysophosphatidic acid receptor.
@en
GPR35 is a novel lysophosphatidic acid receptor.
@nl
P2093
P1476
GPR35 is a novel lysophosphatidic acid receptor
@en
P2093
Mitsuru Shima
Takayuki Sugiura
P304
P356
10.1016/J.BBRC.2010.03.169
P407
P50
P577
2010-03-31T00:00:00Z